Asia Pacific Rehabilitation robots Market Size, Share, and Analysis by 2028

The rehabilitation robots market in APAC is expected to grow from US$ 132.71 million in 2021 to US$ 555.65 million by 2028; it is estimated to grow at a CAGR of 22.7% from 2021 to 2028.

Australia, China, India, Japan, and South Korea are major economies in APAC. Technological innovation in robotic rehabilitation is the major factor driving the growth of the APAC rehabilitation robots market. Rehabilitation robotics is a relatively young and rapidly growing field, with an increasing penetration into the clinical environment. Robotic therapy has shown its effectiveness on motor recovery, but its effectiveness on cognitive recovery is not investigated completely. The most widely studied rehabilitation robots are the MIT-MANUS and its clinical successors, the InMotion2 and InMotion ARM robots (Interactive Motion Technologies, Watertown, MA). Therapy comprises repetitive goal-directed and planar reaching tasks that emphasize shoulder and elbow movements. The low-impedance controller of the InMotionARM is highly compliant when interacting with the client's arm, like hand-over-hand assistance from a therapist during conventional therapy. Although the InMotionARM can provide the passive, active-assistive, active, and resistive modes of therapy, the majority of studies investigated the effects of active-assistive robotic therapy on motor recovery after stroke. Thus, the preference for highly advanced therapy would offer lucrative opportunities for the growth of the medical robot market.       

The 2019 novel coronavirus (2019-nCoV), officially named as COVID-19 by the WHO, has spread to more than 170 countries, including China prompting the WHO to declare the disease as a global pandemic. From its epicenter in China, the novel coronavirus has spread to infect 514,179 people and cause no less than 18,440 deaths in at least 160 countries across a three-month span from January 2020 till date. These figures are according to the World Health Organization (WHO) Situation report as of March 25th. Accompanying the tragic loss of life that the virus has caused is the impact to the global economy, which has reeled from the effects of the pandemic. As research details emerge, the data pool grows exponentially, beyond the capacity of human intelligence alone to handle. The use of robots in the medical sector, to help in areas such as nursing, physical rehabilitation, and surgery, has been a particular priority in Japan and China. Thus, the outbreak of COVID-19 has prompted hospitals to speed up the clinical application of robotic technology in China and Japanese region. Advancements in robotic rehabilitation application such as rehab exercise, neuro robotic rehabilitation, among Others. This has no doubt aided the control of the COVID-19 pandemic and helped to curb its worst effects. Hence, such outbreaks continue, the need for new technological advanced products nationwide increases and thereby positively impacting the market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC rehabilitation robots market. The APAC rehabilitation robots market is expected to grow at a good CAGR during the forecast period.

APAC Rehabilitation Robots Market Segmentation

APAC Rehabilitation Robots Market – By Type

• Exoskeleton Robots
• Therapeutic Robots
• Assistive Robots
• Prosthetic Robots

APAC Rehabilitation Robots Market – By End User

• Rehabilitation Centers
• Hospitals
• Specialty Clinics

APAC Rehabilitation Robots Market, by Country

• Australia
• China
• India
• Japan
• South Korea
• Rest of APAC

APAC Rehabilitation Robots Market - Companies Mentioned

• Cyberdyne Inc.
• DIH Medical
• Ekso Bionics Holdings Inc
• Rewalk Robotics Ltd
• Rex Bionics Ltd
• Toyota Motor Corporation
• VINCENT MEDICAL HOLDINGS LIMITED  

Asia Pacific Rehabilitation robots Report Scope